https://imedsciences.com/ editor_ijims@hotmail.com
ISSN: 2394-4137 (E) 2394-6318 (P)

IJIMS.2016.125

Type of Article: Original Research

Volume 3; Issue 6: June 2016

Page No.: 303-308

DOI: 10.16965/ijims.2016.125

Study on prevalence of Diabetes Mellitus in patients with Pulmonary Tuberculosis

Lokesh Gutta *1, Rajender 2, Meghana S 3, Jhansi Rani 4.

*1 Third Year PG, Department of Pulmonology, Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar. 505001, Telangana, India.

2 Prof & HOD, Department of Pulmonology, Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar. 505001, Telangana, India.

3 Second Year PG, Department of Pulmonology, Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar. 505001, Telangana, India.

4 Assistant Professor, Department of Biochemistry, Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar. 505001, Telangana, India.

CORRESPONDING AUTHOR ADDRESS: Dr.Lokesh Gutta, Third yr PG, Department of Pulmonology, CAIMS, Karimnagar-505001. Telangana, India. E-Mail: meghareddy15@gmail.com

ABSTRACT

Background: A rising prevalence of tuberculosis in diabetics has been seen with age. Active tuberculosis intensifies diabetes mellitus and vice versa; thus, the two diseases constitute a dreaded companion. The dual burden of disease may make the management of both conditions more difficult. Mortality rates in these patients are reported to be several times higher than in non-diabetic pulmonary tuberculosis patients.

Aim: To study the prevalence of diabetes mellitus in patients with Tuberculosis.

Materials and Methods: 400 patients diagnosed as pulmonary tuberculosis at Chalmeda Anand Rao Institute DOTS centre were included in this study.This study was conducted from March 2014 to December 2015. Fasting plasma glucose levels of patients diagnosed with tuberculosis were analyzed and were being managed as per DOTS guidelines.

Results: 400 cases taken up for this study, 256 were males (64%) and 144 were females (36%), the total number of patients found diabetic were 46 (11.5%). Amongst males 28 (10.9%) were found diabetic, of whom known diabetics were 10 (35.7%) (eight on OHA and two on Insulin) and females found diabetic were 18(12.5%), of whom 8 (44%) were known diabetics (six OHA and two Insulin).The total number of diabetics when analyzed was 44 Type II  and two Type I.

Conclusion: In view of the high prevalence of diabetes mellitus, it is recommended that Standard Screening programme for diabetes should be incorporated under DOTS so that early diagnosis and treatment can be done to avoid morbidity and failure of Category-I patients under DOTS.

Key words: Diabetes mellitus, Pulmonary tuberculosis, HbA1C, Chest X-ray.

REFERENCES

  1. Wang CS, Yang CJ, Chen HC, et al. Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiol Infect 2009;137:203-10.
  2. King H, Aubert RE, Herman WH: Global burden of Diabetes 1995–2025: Prevalence, Numerical Estimates and projections. Diabetes Care 1998;21:1414.
  3. World Health Organisation. WHO Report 2008: Global Tuberculosis control, surveillance, planning, financing. WHO/HTM/TB/2008;393:109-112.
  4. Boucot KR et al. Tuberculosis among diabetics: the Philadelphia survey. Am Rev of Tub 1952; 65(1:2):1-50.
  5. Oscarsson PNS, H. Incidence and coincidence of diabetes mellitus and pulmonary tuberculosis in a Swedish county. Acta Med Scand Suppl 1958;335:22-48.
  6. Davidovich D, Aiello CR, Hassan IA. Antitubercular preventive examination in diabetics. Sem Med 1963;122:781-4.
  7. Nanda, C.N., Tripathy, S.N. J of Assoc of Phy of India 1968;16:714.
  8. Lahiri, D.C. and Sen, P.K. Indian J Tuberc 1974;21:98-9.
  9. Bahulkar, H.V., Lokhandwala,V.A. Tuberculosis – the social evil. Indian Med J 1951 Feb; 45(2): 44-5.quoted by Deshmukh, 1975.
  10. Ezung T, Devi NT, Singh NT, Singh TB. Pulmonary tuberculosis and diabetes mellitus-a study. Journl of Ind Med Assoc 2002;100:376-80.
  11. Kawamori R. Diabetes and tuberculosis-bad companions. Kekkaku 2004;79(1):25-32.
  12. I. Restrepo, S. P. Fisher-Hoch, J.G. Crespo, et.al. Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect 2007;135:483-91.
  13. Mboussa J, Monabeka H, Kombo M, al. Course of pulmonary tuberculosis in diabetics. Rev Pneumol Clin 2003;59:39-44.
  14. Amrit Guptan, Ashok shah.Tuberculosis and Diabetes:An appraisal. Ind J Tub 2000;47:3.
  15. Hendy M, Stableforth D. The effect of established diabetes mellitus on the presentation of infiltrative pulmonary tuberculosis in the immigrant Asian community of an inner city area of the United Kingdom. Br J Dis Chest 1983;77:87-90.
  16. Harries AD – Trans R. Links between diabetes mellitus and tuberculosis: should we integrate screening and care? Soc Trop Med Hyg 01-JAN-2009;103(1):1-2.
  17. Jhansi Rani C. Role of Albumin In Estimation of Hba1c In South Indian Subjects. Int J of Sc Research.2016;5(4):650-651.
  18. Coleman PG, Thomas DW, Zimmet PZ et al. Community Organizations for diabetes Action, New classification and criteria for the diagnosis of diabetes mellitus; Interpretation of Capillary Blood Glucose Values Revision Date: September 2006
  19. Ramachandran A, Snehalatha C, Kapur A, et al. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia2001;44(9):1094-101.
  20. Alfredo Pone de leon MD, Ma, De Lourdes Garcia Garcia,Cecila Garcia Sancho. TB and diabetes in Southern Mexico. Diabetes Care 2004;27:1584-90.
  21. Alisjahbana B, Sahiratmadja E, Nelwan EJ, et al. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Inf Dis 2007;45:428-35.
  22. Banu Rekha VV, Balasubramanian R, Swaminathan S, et al. Sputum conversion at the end of intensive phase of category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: an analysis of risk factors. Ind J Med Res 2007;126:452-8.
  23. Guler M, Unsal E, Dursun B, al. Factors influencing sputum smear and culture conversion time among patients with new cases of pulmonary tuberculosis. Int J Clin Pract 2007;61:231-5.
  24. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003;26: 12-4.
  25. Stevenson CR, Critchley JA, Forouhi NG, et al. Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn 2007;3:228-45.
  26. Dye C, Lonnroth K, Jaramillo E, Williams BG, Raviglione M. Trends in tuberculosis incidence and their determinants in 134 countries. Bull World Health Organ 2009;87: 683-91.
  27. Lonnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 2009;68: 2240-6.
  28. Creswell J, Raviglione M, Ottmani S, Migliori GB, Uplekar M, et al. Tuberculosis and noncommunicable diseases: neglected links and missed opportunities. Eur Res J 2011 May;37(5):1269-82.
  29. Anil K, Anthony D, Harries, Knut Lönnroth, IbC Bygbjerg and Pierre Lefebvre. Diabetes and Tuberculosis – Old associates posing a renewed Public Health Challenge. European Endocrinology 2009;5(1):10-2.
  30. Pablos-Mendez A, Blustein J, Knirsch CA. The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health 1997;87:574-9.
  31. Meghan A Baker, Anthony D Harries, Christie Y Jeon, Jessica E Hart, Knut Lönnroth et al. The impact of diabetes on tuberculosis treatment outcomes: A systematic review. BMC Medicine 2011;9:81.
  32. Perez-Guzman C, et al. Progressive age-related changes in pulmonary tuberculosis images and the effect ofdiabetes. American Journal of Respiratory and Critical Care Medicine 2000;162:1738-40.
  33. Oursler KK, et al. Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clinical Infectious Diseases 2002;34:752-9.
  34. Bashar M, et al. Increased incidence of multidrug resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997. Chest 2001;120:1514-9.
  35. Fisher-Hoch SP, Whitney E, Mccormick JB, Crespo JG, SmithB, Perez AP, et al. Type 2 diabetes and multidrug-resistant tuberculosis. Scand J Infect di 2008;40:888-9336.
  36. Suarez-García I, Rodríguez-Blanco A, Vidal-PérezGarcía-Viejo ML, Jaras-Hernandez MJ, López OJ, et al.Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain. Eur J Clin Microbiol Inf Dis 2009;28:325-30.
  37. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
  38. Raviglione M. XDR-TB: entering the post-antibiotic era? Int J Tub Lung Dis 2006; 10:1185-7.
  39. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003;163:1009-21.
  40. Wells CD, Cegielski JP, Nelson LJ, et al. HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 2007;196 Suppl. 1:S86-107.
  41. Lonnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 2009;68: 2240-6.
  42. Stevenson CR, Forouhi NG, Roglic G, et al. Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health 2007;7:234.
Download Full Text TOC